| Title: |
MPN-136 Pelabresib Plus Ruxolitinib Combination Therapy in JAK Inhibitor-Naïve Patients With Myelofibrosis in the Phase 3 MANIFEST-2 Study: Preliminary Evidence of Bone Marrow Recovery |
| Authors: |
Mascarenhas, John 1; Rampal, Raajit K. 2; Vannucchi, Alessandro M. 3; Gupta, Vikas 4; Oh, Stephen T. 5; Kuykendall, Andrew T. 6; Mesa, Ruben 7; Kiladjian, Jean-Jacques 8; Talpaz, Moshe 9; Kremyanskaya, Marina 9; Scandura, Joseph 10; Kräft, Tabea 11; Eliane, Jean-Pierre 12; Chang, Tzuu-Wang 12; Cui, Jike 12; Kuffer, Christian 11; Boxhammer, Rainer 11; Harrison, Claire 13 |
| Source: |
In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S417-S418 |
| Database: |
ScienceDirect |